Antibiotic Lock Solutions in the Prevention of Catheter Related Bacteremia

Completed · Phase 4

Conditions studied: ESRD

In brief

To study the efficacy of an antibacterial/anticoagulant solution instilled into the hemodialysis (HD) catheters after each treatment ("antibiotic lock solution - ALS") to prevent catheter related bacteremia (CRB) and to salvage catheters with established CRB.

Key facts

Study ID

NCT00294502

Run by

Henry Ford Health System

People needed

120

Starts

2003-09-01

Expected to finish

2004-05-01

Last updated by the study team

2006-02-22

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• ESRD patients with tunnelled catheters

You may not qualify if…

• patients on IV abx for infections, patients who have AV graft, AV fistulas

Where it is running

• Henry Ford Hospital — Detroit, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.